Adtalem Global Education (NYSE:CVSA) Stock Price Up 12% After Earnings Beat

Adtalem Global Education Inc. (NYSE:CVSAGet Free Report)’s stock price was up 12% on Friday after the company announced better than expected quarterly earnings. The company traded as high as $128.95 and last traded at $130.9840. Approximately 115,362 shares traded hands during trading, a decline of 70% from the average daily volume of 387,121 shares. The stock had previously closed at $117.00.

The company reported $1.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. The business had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Truist Financial assumed coverage on Adtalem Global Education in a research report on Tuesday, March 24th. They issued a “buy” rating and a $130.00 target price on the stock. Weiss Ratings assumed coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Finally, Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Friday, April 17th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Adtalem Global Education presently has an average rating of “Moderate Buy” and a consensus target price of $150.00.

Check Out Our Latest Stock Analysis on CVSA

Insider Activity

In other news, Director Michael W. Malafronte bought 15,305 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The shares were purchased at an average cost of $100.86 per share, with a total value of $1,543,662.30. Following the transaction, the director directly owned 16,505 shares in the company, valued at approximately $1,664,694.30. The trade was a 1,275.42% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last 90 days, insiders acquired 37,236 shares of company stock valued at $3,752,866. 2.50% of the stock is owned by corporate insiders.

Adtalem Global Education Trading Up 12.0%

The business has a 50-day moving average price of $110.78. The company has a market capitalization of $4.52 billion, a P/E ratio of 19.21, a price-to-earnings-growth ratio of 0.98 and a beta of 0.63. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.68 and a quick ratio of 0.68.

About Adtalem Global Education

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

Recommended Stories

Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.